Symbol: |
PLXNA2
|
Description: |
plexin A2 [Source:HGNC Symbol;Acc:9100]
|
Location: |
Chr1:208195587-208417665[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:63
Gene |
Compound |
Gen_sig |
Exp_pattern |
PLXNA2 |
NSC 112789 |
0.021 |
Down |
PLXNA2 |
NSC 148201 |
0.02 |
Up |
PLXNA2 |
Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- |
0.043 |
Down |
PLXNA2 |
NSC 26669 |
0.038 |
Down |
PLXNA2 |
NSC 270927 |
0.043 |
Up |
PLXNA2 |
GEL-I-195-1 |
0.034 |
Up |
PLXNA2 |
NSC 295642 |
0.016 |
Down |
PLXNA2 |
NSC 29638 |
0.016 |
Up |
PLXNA2 |
1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride |
0.016 |
Up |
PLXNA2 |
NSC 328130 |
0.031 |
Up |
PLXNA2 |
NSC 382006 |
0.044 |
Up |
PLXNA2 |
RAPAMYCIN PRODRUG |
0.035 |
Up |
PLXNA2 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.043 |
Up |
PLXNA2 |
Choline, hydroxide, 3-methoxy- 2-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt |
0.039 |
Down |
PLXNA2 |
Olomoucine |
0.001 |
Up |
Expression pattern: Sensitivity / Resistance
Total:5 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
|
miRNA:
~ Export ~
|
Records:6
Gene |
Gen_transcript |
miRNA |
miR_location |
PLXNA2 |
ENST00000321063 |
hsa-mir-146a-3p |
Chr5:159912415-159912436[+] |
PLXNA2 |
ENST00000321063 |
hsa-mir-500a-3p |
ChrX:49773090-49773111[+] |
PLXNA2 |
ENST00000321063 |
hsa-mir-501-3p |
ChrX:49774380-49774401[+] |
PLXNA2 |
ENST00000321063 |
hsa-mir-502-3p |
ChrX:49779257-49779278[+] |
PLXNA2 |
ENST00000321063 |
hsa-mir-92b-3p |
Chr1:155165028-155165049[+] |
PLXNA2 |
ENST00000321063 |
hsa-mir-936 |
Chr10:105807909-105807930[-] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|